AzTrials
AzTrials

Dental AnxietyNCT04226651

The Effectiveness of Audiovisual Distraction Behavior Guidance Technique in Children With Dental Anxiety

A study testing Virtual Reality Device and Protective glasses in people with Dental Anxiety and Dental Pain and Sensation Disorder, run by Cumhuriyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized, two-armed, placebo-controlled, cross-over, controlled trial aimed to evaluate the effect of virtual reality exposure therapy (VRET) on dental anxiety, pain, and behaviour among children undergoing dental treatment under local anaesthesia. Read more about this study

Who is it for?
Ages 7 to 11 yearsHealthy volunteers can take part
What is being tested?
Virtual Reality Device and Protective glasses
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
11 Mar 2019to 16 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Requiring restorative treatment for first mandibular permanent molar tooth with dentin caries in each mandibular quadrant with a bilateral inferior alveolar nerve block
  • Co-operative ability

Who cannot join

  • Systemic or mental illnesses
  • Limited audiovisual capabilities
  • Acute dental pain or trauma

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Burak Buldur

    Sivas, Kampus, 58140

Other trials in Turkey (Türkiye)

About this study

Official title: Does Virtual Reality Exposure Therapy Affect Children's Dental Anxiety, Pain, and Behaviour? A Randomized, Placebo-Controlled Cross-Over Trial

This randomized, two-armed, placebo-controlled, cross-over, controlled trial aimed to evaluate the effect of virtual reality exposure therapy (VRET) on dental anxiety, pain, and behaviour among children undergoing dental treatment under local anaesthesia. The null hypotheses were as follows: VRET has no effect on reducing dental anxiety and dental pain scores of participants; and there is no difference between subjective and objective measure scores of dental anxiety and pain when VRET and attention palcebo-controlled (APC) groups are used to reduce anxiety in children undergoing dental treatment with local anaesthesia.

Read the detailed description

This randomized, two-armed, placebo-controlled, cross-over, controlled trial adhered to the principles of the Declaration of Helsinki, good clinical practice guidelines, and applicable regulatory requirements. Ethics approval was obtained from the Health Ethics Committee of Sivas Cumhuriyet University (Sivas, Turkey; ID: 2018-02/08). All parents or guardians of children were educated about the study before enrollment and provided informed written consent to participate. The trial adhered to the Consolidated Standards of Reporting Trials (CONSORT) guidelines.

The parameters used to calculate the sample size included a 95% confidence interval (CI), 80% statistical power, and a standard deviation of 1.90; accordingly, at least 64 subjects were required. This number was adjusted to 76 subjects to compensate for a projected loss of approximately 20% during follow-up. Thus, 76 healthy subjects between 7 and 11 years of age were included in the study. Participants who fulfilled the following criteria were included: systemically and mentally healthy; required restorative treatment for first mandibular permanent molar tooth with dentin caries in each mandibular quadrant with a bilateral inferior alveolar nerve block; absence of co-operative disability; and Frankl Scale score 2 or 3 during first dental examination. Patients with systemic or mental illnesses, reduced audiovisual capabilities, acute dental pain or trauma, those with previous painful or negative dental experience, and those who were extremely uncooperative were excluded.

The present randomized, two-armed, within-subject, cross-over, controlled trial included patients who applied to Department of Pediatric Dentistry, Cumhuriyet University, for routine dental treatment.The study comprised three visits: V0, baseline dental examination and inclusion; V1, first restorative treatment session; and V2, second restorative treatment session for symmetrical teeth. The initial oral and radiographic examination and Frankl Behaviour Scale scoring of all patients were performed by one experienced and pre-calibrated researcher. A dental assistant not participating in the study used a random-order generator (http://www.random.org) to randomize patients to the experimental group according to block randomization.

Eligible participants were treated in two different appointments: protective glasses only, without distraction (APC); or with the treatment condition (VRET). All procedures were performed by a single experienced and calibrated paediatric dentist (BB).

Participants were randomly assigned by a computer algorithm to receive VR with the first or second sequential dental treatment session and with protective glasses for the other treatment session. The investigators were blinded to treatment sequence until before the first dental treatment was to begin. Before VRET, the VR headset was shown to the patients, who were permitted to handle it. This enabled the patient to recognize the device and be familiar with it before treatment. Before starting treatment, the VR headset was placed on each patient's head, and the patient was asked whether the device caused pain or discomfort, and the patient's consent was confirmed. In the APC group, each patient was informed about the dental procedure and was provided with protective glasses. All patients were told that they were wearing these glasses to ensure a pain- and stress-free treatment, and that the dentist would devote additional attention to the treatment. This aimed to provide the patient with feeling like being in an experimental session. The reason for choosing an APC group with the routine protective glasses without distraction was to mitigate possible Hawthorne effects.

Regardless of experimental group, in the first treatment session, the mandibular first permanent molar tooth of each patient was restored with composite filling under local anaesthesia, while the opposite symmetrical tooth was treated in the second session. The duration of treatment in each session was noted and defined as the time from the subject sat on the chair to occlusal adjustment of restoration. First, the teeth were cleaned using fluoride-free prophylactic paste. The preparation was limited to removal of the caries, followed by rounding of the inner line and point angles. Cavity preparation was performed using an 80 µm grit diamond bur and completed using a 25 µm grit diamond bur (Intensiv, Viganello-Lugano, Switzerland). Isolation and contamination were controlled with suction and cotton rollers. In cases for which this was not sufficient, a rubber dam was used. Metal matrix bands and wooden wedges were also used where necessary.

Statistical analyses were performed using SPSS version 22.0 (IBM Corporation, Armonk, NY, USA). Descriptive analysis was used to summarize demographic characteristics and responses of the participants on each scale. The chi-squared test was used to compare age and sex differences at baseline. Repeated measures ANOVA was performed to analyse changes according treatment group, dental visit sequence and time point of treatment procedure. Differences with p < 0.05 were considered to be statistically significant.

Being tested
Virtual Reality Device, Protective glasses
Medical subject headings
Toothache, Sensation Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality DeviceDevice

    The Virtual Reality system (PlayStation 4 VR, Sony Inc.) is a simple and easy to use distraction device. The system consists of a screen mounted on a binocular headset connected to a console or personal computer. The head-mounted display provides a high-resolution visual display and unmutes the sound from the headphones using a soundproof mechanism that provides clear sound.

  • Protective glassesDevice

    Each patient was informed about the dental procedure and was provided with protective glasses. All patients were told that they were wearing these glasses to ensure a pain- and stress-free treatment, and that the dentist would devote additional attention to the treatment.

Study groups in NCT04226651
Study groupRoleWhat they receive
First dental visitActive comparatorVirtual Reality Exposure Therapy
Receives: Device: Virtual Reality Device
Second Dental VisitPlacebo comparatorProtective Glasses
Receives: Device: Protective glasses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dental Anxiety

    Dental anxiety will be assessed using the Heart Rate with a portable pulse oximetry device

    Measured: Time 0: a minute after sitting in the dental unit ; Time 1: 1 min before local anaesthesia; Time 2: 1 min after local anaesthesia; Time 3: 1 min before end of the treatment

  2. Dental Anxiety

    Dental anxiety was assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS) and Facial Image Scale (FIS)

    Measured: Visit 0: 5 min before first inclusion visit, Visit 1: 5 min before first dental treatment visit,Visit 2: 5 min before second dental treatment visit,

Secondary outcomes (3)
  1. Dental Pain

    Dental pain will be assessed using the Heart Rate with a portable pulse oximetry device

    Measured: Time 0: a minute after sitting in the dental unit ; Time 1: 1 min before local anaesthesia; Time 2: 1 min after local anaesthesia; Time 3: 1 min before end of the treatment

  2. Dental Pain

    Dental pain will be assessed using the Wong-Bakers Faces Pain Scale (WBS)

    Measured: Time 2: 1 min after local anaesthesia; Time 3: 1 min before end of the treatment

  3. Dental behavior

    Dental pain will be assessed using the Frankl Behaviour Scale

    Measured: Time 3: 1 min before end of the treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2020
  2. Study start11 Mar 2019
  3. Primary completion18 Jun 2019
  4. Study completion16 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
randomized, two-armed, within-subject, cross-over, controlled
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04226651
Sponsor's protocol ID
DIS-217
Status last verified
Jan 2020
First submitted
8 Jan 2020
Last updated
27 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Not planned yet.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Device and Protective glasses in people with Dental Anxiety and Dental Pain and Sensation Disorder, run by Cumhuriyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dental Anxiety (time frame: Time 0: a minute after sitting in the dental unit ; Time 1: 1 min before local anaesthesia; Time 2: 1 min after local anaesthesia; Time 3: 1 min before end of the treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in